Striatal synaptophysin expression and haloperidol-induced synaptic plasticity.
Synaptophysin is a presynaptic vesicle protein and a marker of synaptic density. We have studied the expression of its encoding mRNA in the brains of rats treated with haloperidol (2 mg kg-1 d-1) for two weeks. A significant increase in synaptophysin mRNA content was observed in the dorsolateral striatum but not in other brain areas compared with control animals. A similar trend was observed for synaptophysin immunoreactivity. Quantification of synaptophysin mRNA per cell showed that the increase was pronounced in large putatively cholinergic, striatal neurones. These data provide further evidence that localized synaptic plasticity occurs after neuroleptic treatment and indicate that such alterations are manifested in terms of expression of a synaptic protein gene by striatal neurones.
Eastwood
S L
SL
University Department of Psychiatry, Warneford Hospital, Oxford, UK.
Burnet
P W
PW
Harrison
P J
PJ
D000818:Animals; D001345:Autoradiography; D005625:Frontal Lobe / Q000187:drug effects / Q000378:metabolism; D015870:Gene Expression / Q000187:drug effects; D006220:Haloperidol / Q000494:pharmacology*; D006651:Histocytochemistry; D017403:In Situ Hybridization; D008297:Male; D017072:Neostriatum / Q000187:drug effects / Q000378:metabolism*; D009473:Neuronal Plasticity / Q000187:drug effects*; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017207:Rats, Sprague-Dawley; D013569:Synapses / Q000187:drug effects*; D016708:Synaptophysin / Q000096:biosynthesis*
D012333:RNA, Messenger; D016708:Synaptophysin; D006220:Haloperidol